Putative receptor-binding sites of hepatitis E virus.

A truncated structural protein of hepatitis E virus (HEV), p239, occurs as 23 nm particles consisting of partial homodimers. As the latter resemble the HEV capsomere structurally and antigenically, it was postulated that the recombinant protein may serve as a probe for the HEV receptor. This hypothesis was supported by findings that purified p239 bound and penetrated different cell lines that are susceptible to HEV, and inhibited HEV infection of these cells. The binding was blocked by four of six monoclonal antibodies (mAbs) reactive against the dimeric domain of p239, and by two of three mAbs reactive against its monomeric domain, suggesting that binding may involve a portion of each domain. Mutation affecting the monomeric domain had no effect on binding or capacity to block HEV infection, whereas that affecting the dimeric domain diminished binding of the mutant peptide markedly and abrogated its capacity to block HEV infection. These results suggest that HEV infection might involve distinct receptor-binding sites.

[1]  N. Xia,et al.  Difference of T cell and B cell activation in two homologous proteins with similar antigenicity but great distinct immunogenicity. , 2007, Molecular immunology.

[2]  E. Kusano,et al.  Development and evaluation of an efficient cell-culture system for Hepatitis E virus. , 2007, The Journal of general virology.

[3]  Jun Zhang,et al.  Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. , 2005, Vaccine.

[4]  N. Xia,et al.  A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. , 2005, Vaccine.

[5]  N. Xia,et al.  Mutational Analysis of Essential Interactions Involved in the Assembly of Hepatitis E Virus Capsid* , 2005, Journal of Biological Chemistry.

[6]  S. Emerson,et al.  In Vitro Replication of Hepatitis E Virus (HEV) Genomes and of an HEV Replicon Expressing Green Fluorescent Protein , 2004, Journal of Virology.

[7]  N. Xia,et al.  Evaluation of antibody‐based and nucleic acid‐based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model , 2003, Journal of medical virology.

[8]  L. Xing,et al.  Recombinant hepatitis E capsid protein self-assembles into a dual-domain T = 1 particle presenting native virus epitopes. , 1999, Virology.

[9]  J. Meng,et al.  A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E , 1997, Journal of clinical microbiology.

[10]  R. Kawaguchi,et al.  I. hepatitis E virus (87A strain) propagated in A549 cells , 1995, Journal of medical virology.

[11]  A. W. Tam,et al.  Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome , 1991, Virology.

[12]  S. Emerson,et al.  Animal models of hepatitis A and E. , 2001, ILAR journal.